ARTICLE | Company News
ImClone deal
October 4, 1993 7:00 AM UTC
IMCL will receive research support from Cyanamid, including milestone payments, and royalties on sales. The pharma company has exclusive worldwide rights to manufacture and sell vaccines developed by ...